Trials / Approved For Marketing
Approved For MarketingNCT02471781
Zenith® TX2® Low Profile TAA Endovascular Graft
Zenith® TX2® Low Profile TAA Endovascular Graft Clinical Study
- Status
- Approved For Marketing
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Cook Group Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Zenith TX2 Low Profile TAA Endovascular Graft extended study is to collect confirmatory safety and effectiveness data. The Zenith TX2 Low Profile TAA Endovascular Graft is indicated for the treatment of patients with a descending thoracic aortic aneurysm or penetrating ulcer and has an anatomy suitable for repair.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zenith TX2 Low Profile TAA Endovascular Graft | Endovascular treatment of patients with aneurysms or ulcers of the descending thoracic aorta having morphology suitable for endovascular repair. |
Timeline
- First posted
- 2015-06-15
- Last updated
- 2020-01-18
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02471781. Inclusion in this directory is not an endorsement.